Suppr超能文献

[氯氮平]

[Clozapine].

作者信息

Inada Ken, Ishigooka Jun

机构信息

Department of Psychiatry, School of Medicine, Tokyo Women's Medical University.

出版信息

Nihon Rinsho. 2013 Apr;71(4):678-83.

Abstract

Clozapine is a drug used in the management of treatment-resistant schizophrenia. Numerous clinical trials, including randomized double-blind clinical trials and large cohort studies, have revealed that clozapine is more effective than any other antipsychotic drugs. However, the same studies have also shown that this drug has several adverse effects such as an agranulocytosis. Therefore, in Japan, clozapine is approved for administration to only patients with treatment-resistant schizophrenia in whom treatment with other antipsychotic drugs was ineffective. Clozapine is prescribed only at approved institutes that are under the registration called Clozaril Patient Monitoring Service (CPMS), and white blood cell counts and prescription dosage of clozapine are strictly monitored under this service.

摘要

氯氮平是一种用于治疗难治性精神分裂症的药物。众多临床试验,包括随机双盲临床试验和大型队列研究,均表明氯氮平比其他任何抗精神病药物都更有效。然而,同样的研究也表明,这种药物有多种不良反应,如粒细胞缺乏症。因此,在日本,氯氮平仅被批准用于其他抗精神病药物治疗无效的难治性精神分裂症患者。氯氮平仅在名为氯氮平患者监测服务(CPMS)注册的获批机构开具处方,并且在此服务下会严格监测白细胞计数和氯氮平的处方剂量。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验